Ultrasmall superparamagnetic particles of iron oxide allow for the detection of metastases in normal sized pelvic lymph nodes of patients with bladder and/or prostate cancer.

PubWeight™: 2.15‹?› | Rank: Top 2%

🔗 View Article (PMID 23084842)

Published in Eur J Cancer on October 18, 2012

Authors

Maria Triantafyllou1, Urs E Studer, Frédéric D Birkhäuser, Achim Fleischmann, Lauren J Bains, Giuseppe Petralia, Andreas Christe, Johannes M Froehlich, Harriet C Thoeny

Author Affiliations

1: Department of Radiology, Institute for Diagnostic, Interventional, and Pediatric Radiology, Inselspital University Hospital Bern, Switzerland.

Associated clinical trials:

USPIO-enhanced and Diffusion-weighted MRI for the Detection of Pelvic Lymph Node Metastases | NCT00622973

Articles citing this

A comprehensive literatures update of clinical researches of superparamagnetic resonance iron oxide nanoparticles for magnetic resonance imaging. Quant Imaging Med Surg (2017) 1.38

Comments on Ultrasmall superparamagnetic particles of iron oxide allow for the detection of metastases in normal sized pelvic lymph nodes of patients with bladder and/or prostate cancer, Triantafyllou et al., European Journal of Cancer, published online 22 October 2012. Eur J Cancer (2013) 1.09

Optimization of sentinel lymph node mapping in bladder cancer using near-infrared fluorescence imaging. J Surg Oncol (2014) 0.82

Whole-body diffusion-weighted imaging: is it all we need for detecting metastases in melanoma patients? Eur Radiol (2013) 0.82

Individualized image-based lymph node irradiation for prostate cancer. Nat Rev Urol (2013) 0.79

Molecular and functional imaging for detection of lymph node metastases in prostate cancer. Int J Mol Sci (2013) 0.78

Lymph node assessment in endometrial cancer: towards personalized medicine. Obstet Gynecol Int (2013) 0.77

Imaging Tumor Necrosis with Ferumoxytol. PLoS One (2015) 0.77

Nanotechnology applications in thoracic surgery. Eur J Cardiothorac Surg (2016) 0.77

Diffusion-weighted magnetic resonance imaging in management of bladder cancer, particularly with multimodal bladder-sparing strategy. World J Radiol (2014) 0.76

Current Staging Procedures in Urinary Bladder Cancer. Diagnostics (Basel) (2013) 0.75

Utility of preoperative ferumoxtran-10 MRI to evaluate retroperitoneal lymph node metastasis in advanced cervical cancer: Results of ACRIN 6671/GOG 0233. Eur J Radiol Open (2015) 0.75

Nanotechnology in bladder cancer: current state of development and clinical practice. Nanomedicine (Lond) (2015) 0.75

Beyond penile cancer, is there a role for sentinel node biopsy in urological malignancies? Clin Transl Imaging (2016) 0.75

Response to the letter to the editor from Ansje S. Fortuin and Jelle O. Barentsz--Harriet C. Thoeny for the authors. Eur J Cancer (2013) 0.75

Articles by these authors

Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia (2009) 7.44

Readaptation of the peritoneum following extended pelvic lymphadenectomy and cystectomy has a significant beneficial impact on early postoperative recovery and complications: results of a prospective randomized trial. Eur Urol (2010) 4.18

Pelvic lymph node dissection in prostate cancer. Eur Urol (2009) 3.93

Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? J Urol (2003) 3.58

Antegrade perfusion with bacillus Calmette-Guérin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit? Eur Urol (2011) 3.47

Long-term renal function after urinary diversion by ileal conduit or orthotopic ileal bladder substitution. Eur Urol (2011) 3.44

The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study. Eur Urol (2007) 3.20

Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol (2008) 2.83

Twenty years experience with an ileal orthotopic low pressure bladder substitute--lessons to be learned. J Urol (2006) 2.82

Contemporary role of androgen deprivation therapy for prostate cancer. Eur Urol (2011) 2.68

Urinary diversion. Urology (2007) 2.65

Nerve sparing open radical retropubic prostatectomy--does it have an impact on urinary continence? J Urol (2006) 2.65

Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer. Sci Transl Med (2012) 2.64

Reliable gene expression measurements from degraded RNA by quantitative real-time PCR depend on short amplicons and a proper normalization. Lab Invest (2005) 2.60

A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder. Eur Urol (2009) 2.55

Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy. Eur Urol (2008) 2.46

Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy. J Clin Oncol (2003) 2.33

Is pelvic lymph node dissection necessary in patients with a serum PSA<10ng/ml undergoing radical prostatectomy for prostate cancer? Eur Urol (2006) 2.32

Restrictive deferred hydration combined with preemptive norepinephrine infusion during radical cystectomy reduces postoperative complications and hospitalization time: a randomized clinical trial. Anesthesiology (2014) 2.25

Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. J Urol (2011) 2.14

Occlusion of seminal vesicles increases sexual activity in a mouse model. Eur Urol (2012) 2.03

Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients. Eur Urol (2009) 1.99

A prospective randomized trial comparing 2 lithotriptors for stone disintegration and induced renal trauma. J Urol (2003) 1.84

Metastases in normal-sized pelvic lymph nodes: detection with diffusion-weighted MR imaging. Radiology (2014) 1.78

Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer. Eur Urol (2013) 1.77

Do patients benefit from routine follow-up to detect recurrences after radical cystectomy and ileal orthotopic bladder substitution? Eur Urol (2010) 1.76

Radionecrosis or tumor recurrence after radiation of laryngeal and hypopharyngeal carcinomas. Otolaryngol Head Neck Surg (2006) 1.69

Long-term results of standard procedures in urology: the ileal neobladder. World J Urol (2006) 1.68

Extracorporeal shock wave lithotripsy of lower calyx calculi: how much is treatment outcome influenced by the anatomy of the collecting system? Eur Urol (2007) 1.68

Is newer always better? A comparative study of 3 lithotriptor generations. J Urol (2005) 1.67

Ultrasound assessment of detrusor thickness in men-can it predict bladder outlet obstruction and replace pressure flow study? J Urol (2006) 1.65

Individualized seminal vesicle sparing cystoprostatectomy combined with ileal orthotopic bladder substitution achieves good functional results. J Urol (2010) 1.64

Smoking negatively impacts renal cell carcinoma overall and cancer-specific survival. Cancer (2011) 1.64

Detection rate and operating time required for gamma probe-guided sentinel lymph node resection after injection of technetium-99m nanocolloid into the prostate with and without preoperative imaging. Eur Urol (2007) 1.64

Prognostic value of microvascular invasion in predicting the cancer specific survival and risk of metastatic disease in renal cell carcinoma: a multicenter investigation. J Urol (2011) 1.63

A prospective randomised trial comparing the modified HM3 with the MODULITH® SLX-F2 lithotripter. Eur Urol (2011) 1.61

Prognostic implications of extracapsular extension of pelvic lymph node metastases in urothelial carcinoma of the bladder. Am J Surg Pathol (2005) 1.61

Is there an indication for frozen section examination of the ureteral margins during cystectomy for transitional cell carcinoma of the bladder? J Urol (2006) 1.59

Renal oxygenation changes during acute unilateral ureteral obstruction: assessment with blood oxygen level-dependent mr imaging--initial experience. Radiology (2008) 1.58

Primary T1G3 bladder cancer: organ preserving approach or immediate cystectomy? J Urol (2004) 1.56

Increased proximal urethral sensory threshold after radical pelvic surgery in women. Neurourol Urodyn (2007) 1.53

Parenteral nutrition does not improve postoperative recovery from radical cystectomy: results of a prospective randomised trial. Eur Urol (2012) 1.52

Lung Pattern Classification for Interstitial Lung Diseases Using a Deep Convolutional Neural Network. IEEE Trans Med Imaging (2016) 1.51

Long-term voiding pattern of patients with ileal orthotopic bladder substitutes. J Urol (2002) 1.50

Is a limited lymph node dissection an adequate staging procedure for prostate cancer? J Urol (2002) 1.50

Long-term outcome of ileal conduit diversion. J Urol (2003) 1.50

The efficiency of excretory urography to detect upper urinary tract tumors after cystectomy for urothelial cancer. J Urol (2007) 1.49

The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer. Eur Urol (2009) 1.49

MR arthrography of the shoulder, hip, and wrist: evaluation of contrast dynamics and image quality with increasing injection-to-imaging time. AJR Am J Roentgenol (2007) 1.47

Capecitabine initially concomitant to radiotherapy then perioperatively administered in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys (2009) 1.46

Extracapsular extension but not the tumour burden of lymph node metastases is an independent adverse risk factor in lymph node-positive bladder cancer. Histopathology (2011) 1.46

Benign prostatic obstruction and parkinson's disease--should transurethral resection of the prostate be avoided? J Urol (2009) 1.45

Is bilateral extended pelvic lymphadenectomy necessary for strictly unilateral invasive bladder cancer? J Urol (2012) 1.45

Outcomes of radical cystectomy with extended lymphadenectomy alone in patients with lymph node-positive bladder cancer who are unfit for or who decline adjuvant chemotherapy. BJU Int (2014) 1.44

ICUD-EAU International Consultation on Bladder Cancer 2012: Urinary diversion. Eur Urol (2012) 1.42

Effect of thalamic deep brain stimulation on lower urinary tract function. Eur Urol (2007) 1.40

Is eligibility for a chemotherapy protocol a good prognostic factor for invasive bladder cancer after radical cystectomy? J Clin Oncol (2004) 1.40

Diabetes mellitus: does it impair urinary continence after radical cystoprostatectomy and ileal orthotopic bladder substitution? Eur Urol (2007) 1.39

Robot-assisted cystectomy: does it meet expectations? Eur Urol (2010) 1.37

Irrigation of continent catheterizable ileal pouches: tap water can replace sterile solutions because it is safe, easy, and economical. Eur Urol (2011) 1.37

Application of 3D documentation and geometric reconstruction methods in traffic accident analysis: with high resolution surface scanning, radiological MSCT/MRI scanning and real data based animation. Forensic Sci Int (2006) 1.27

Postmortem whole-body CT angiography: evaluation of two contrast media solutions. AJR Am J Roentgenol (2008) 1.26

Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours. Eur Urol (2011) 1.24

Bone metastases from prostate cancer: assessing treatment response by using diffusion-weighted imaging and functional diffusion maps--initial observations. Radiology (2010) 1.23

CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: initial experience. Radiology (2007) 1.23

Holmium laser enucleation of the prostate combined with electrocautery resection: the mushroom technique. J Urol (2002) 1.16

Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma. Skeletal Radiol (2010) 1.16

Postmortem unenhanced magnetic resonance imaging of myocardial infarction in correlation to histological infarction age characterization. Eur Heart J (2006) 1.14

Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor. J Clin Oncol (2005) 1.14

Potential influence of the anesthetic technique used during open radical prostatectomy on prostate cancer-related outcome: a retrospective study. Anesthesiology (2010) 1.10

Androgen deprivation therapy for the treatment of prostate cancer: consider both benefits and risks. Eur Urol (2008) 1.08

Evaluation of renal allograft function early after transplantation with diffusion-weighted MR imaging. Eur Radiol (2009) 1.07

Diffusion-weighted MR imaging of upper abdominal organs: field strength and intervendor variability of apparent diffusion coefficients. Radiology (2013) 1.07

Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity? Neurourol Urodyn (2005) 1.07

Alternate or additional findings to stone disease on unenhanced computerized tomography for acute flank pain can impact management. J Urol (2006) 1.06